Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Third occipital nerve pulsed radiofrequency for cervicogenic headache

Official title: Evaluation of the Effectiveness of Third Occipital Nerve Pulsed Radiofrequency Treatment in Patients With Cervicogenic Headache

Run by Ankara City Hospital Bilkent · NCT07366060 · Data updated 2026-11-12

This trial will test whether ultrasound-guided pulsed radiofrequency of the third occipital nerve reduces pain in adults with cervicogenic headache who responded to a diagnostic nerve block.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, Ankara)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedMay 1, 2026
Study endsSeptember 1, 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT07366060 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) diagnosed with cervicogenic headache by ICHD-3, with at least 5 headache days per month, inadequate response to conservative therapy, and who achieved ≥50% pain relief or meaningful improvement after an ultrasound-guided diagnostic third occipital nerve block are ideal candidates.

Probably not a fit

Patients with other secondary headache disorders, signs of cervical nerve root irritation or spinal stenosis, cranio-cervical structural abnormalities, active infection, recent non-pharmacological headache treatments, or who did not have a positive diagnostic block are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Cervicogenic headache arises from cervical spine structures, particularly the C2-3 zygapophyseal joint innervated by the third occipital nerve. This prospective, single-center, open-label interventional study at Ankara City Hospital Bilkent enrolls adults meeting ICHD-3 criteria who show a positive response to an ultrasound-guided diagnostic third occipital nerve block. Eligible participants receive ultrasound-guided pulsed radiofrequency of the third occipital nerve at the C2-3 level using standard protocols, with outcomes measured by pain intensity (VAS), headache frequency, analgesic consumption, and patient-reported measures at predefined follow-up visits. Safety and procedure-related adverse events are monitored throughout the study period.

Why it matters

Potential benefit: If successful, the procedure could provide longer-lasting pain relief, reduce headache frequency, and decrease the need for pain medications without causing permanent nerve damage.

How similar studies have gone: Pulsed radiofrequency applied to occipital nerves and cervical facet-related pain has shown promising results in case series and small trials, but prospective data specifically for third occipital nerve PRF remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Diagnosis of cervicogenic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)
* Availability of cranial and cervical spine imaging
* At least 5 headache days per month
* Inadequate response to pharmacological and/or physical therapy treatments
* Ability to understand and provide written informed consent
* Positive response to ultrasound-guided diagnostic third occipital nerve block, defined as at least 50% reduction in pain intensity or patient-reported meaningful improvement

Exclusion Criteria:

* Secondary headache disorders other than cervicogenic headache according to ICHD-3
* Signs or symptoms of cervical nerve root irritation and/or spinal stenosis
* Sensory deficit in the greater occipital nerve dermatome
* Cranio-cervical structural defects or anatomical abnormalities at or near the target site
* Local or systemic infection
* Non-pharmacological headache treatment within the last 3 months (e.g., physical therapy, botulinum toxin A, acupuncture, ozone therapy, cognitive behavioral therapy)
* Pregnancy or suspected pregnancy
* Known allergy to local anesthetic agents
* History of malignancy
* Known organic disease of the brain or spinal cord
* History of cranial or cervical surgery within the last 12 months
* Bleeding or coagulation disorders or use of oral anticoagulant therapy
* Comorbid conditions that may cause headache (e.g., uncontrolled hypertension, intracranial lesions)
* Conditions that may interfere with treatment adherence or outcome assessment (e.g., psychiatric disorders, dementia)
* Request for re-treatment due to development of contralateral pain or other pain conditions during follow-up
* Refusal to undergo the intervention or withdrawal of consent at any stage of the study

Where it's running

  • Ankara City Hospital Bilkent
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.